Novel Platforms for Preclinical Antibody Discovery

 11AM-12PM EDT | August 11, 2026

Antibodies are powerful preventive and therapeutic tools against microbes, cancers, autoimmune disorders, and many other diseases. However, traditional antibody discovery approaches often face major limitations, including low efficiency, high costs, high failure rates, logistical barriers, limited scalability, and long turnaround times.